Sanofi India Limited manufactures and trades in drugs and pharmaceutical products in India, Singapore and internationally. The company offers pharmaceutical products in various therapeutic areas, such as diabetes, cardiology, anti-infectives, and central nervous system under the Lantus, Toujeo, Soliqua, Clexane, Amaryl, Cardace, Lasix, Lasilactone, Glimepiride, Cetapin, Targocid, Frisium, Targocio, Combiflam, DePura, Allegra, Baralgan, BUSCOGAST, Dulcoflex, Enterogermina, Novalgin, and Avil brands through independent distributors. It also exports its products. The company was formerly known as Aventis Pharma Limited and changed its name to Sanofi India Limited in May 2012. The company was incorporated in 1956 and is headquartered in Mumbai, India. Sanofi India Limited operates as a subsidiary of Hoechst GmbH.
Low
3,001.10
High
4,898.00
Low
3,001.10
High
3,056.30
Company's profit divided by outstanding shares.
Ratio of share price to its earnings per share.
Total number of outstanding shares.
Gap between today's open and yesterday's close.
Average daily traded volume.
Highest price reached in the last 30 days.
Lowest price reached in the last 30 days.
Highest price reached in the last six months.
Lowest price reached in the last six months.
Highest price reached in the last year.
Lowest price reached in the last year.
How Sanofi India Limited stacks up against its Drug Manufacturers - General peers on price, valuation and the 52-week range. Tap any column header to sort.
| # | Name | Price | Chg % | P/E | EPS | Mkt Cap (Cr) | 1M % | 1Y % | 52W H/L |
|---|---|---|---|---|---|---|---|---|---|
| 1 | SANOFI Sanofi India Limited | 3,040.00 | 0.56% | 21.62 | 140.59 | 6,995 | 7.23% | 40.91% | 4,898.00 / 3,001.10 |
| 2 | CORONA CORONA REMEDIES LIMITED | 2,021.10 | 3.45% | 62.11 | 32.54 | 12,412 | 5.96% | 42.93% | 2,292.40 / 1,336.60 |
| 3 | GLAXO GlaxoSmithKline Pharmaceuticals Limited | 2,760.00 | 0.34% | 43.77 | 63.05 | 46,965 | 6.56% | 0.93% | 3,120.70 / 2,088.10 |
| 4 | MARKSANS Marksans Pharma Limited | 323.05 | 0.23% | 28.32 | 11.41 | 14,719 | 1.00% | 90.70% | 350.95 / 155.00 |
| 5 | NGLFINE NGL Fine-Chem Limited | 2,900.00 | 0.33% | 31.27 | 92.73 | 1,792 | 1.19% | 102.51% | 3,602.00 / 1,271.00 |
| 6 | PFIZER Pfizer Limited | 3,857.00 | 0.47% | 24.00 | 160.70 | 17,654 | 20.77% | 25.83% | 5,578.50 / 3,792.10 |
| 7 | RUBICON RUBICON RESEARCH LIMITED | 1,628.00 | 0.53% | 93.28 | 17.45 | 26,949 | 8.34% | 159.03% | 1,899.00 / 570.75 |
| 8 | SAIPARENT SAI PARENTERALS LIMITED | 522.80 | 1.23% | 106.53 | 4.91 | 2,310 | 0.43% | 28.40% | 706.00 / 400.00 |
| 9 | SANOFICONR SANOFI CONS HEALTHC IND L | 3,775.20 | 0.73% | 32.68 | 115.51 | 8,722 | 10.15% | 26.46% | 5,255.00 / 3,691.00 |
| 10 | SENORES SENORES PHARMACEUTICALS L | 1,335.30 | 3.64% | 49.39 | 27.03 | 6,150 | 11.45% | 93.48% | 1,599.00 / 684.60 |
| 11 | SMSPHARMA SMS Pharmaceuticals Limited | 470.95 | 1.19% | 42.23 | 11.15 | 4,411 | 32.98% | 98.04% | 494.45 / 245.21 |
| 12 | TTKHLTCARE TTK Healthcare Limited | 1,012.20 | 1.06% | 19.34 | 52.34 | 1,431 | 7.52% | 14.00% | 1,247.00 / 735.00 |